日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recent advances in radiotherapy of breast cancer

乳腺癌放射治疗的最新进展

Haussmann, Jan; Corradini, Stefanie; Nestle-Kraemling, Carolin; Bölke, Edwin; Njanang, Freddy Joel Djiepmo; Tamaskovics, Bálint; Orth, Klaus; Ruckhaeberle, Eugen; Fehm, Tanja; Mohrmann, Svjetlana; Simiantonakis, Ioannis; Budach, Wilfried; Matuschek, Christiane

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance

诊断性白细胞分离术能够对单个循环肿瘤细胞进行可靠的转录组分析,从而表征细胞间异质性及其内分泌耐药性。

Reinhardt, Florian; Franken, André; Meier-Stiegen, Franziska; Driemel, Christiane; Stoecklein, Nikolas H; Fischer, Johannes C; Niederacher, Dieter; Ruckhaeberle, Eugen; Fehm, Tanja; Neubauer, Hans

Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer

循环肿瘤细胞在乳腺癌分子亚型中的预后意义

Banys-Paluchowski, M; Schneck, H; Blassl, C; Schultz, S; Meier-Stiegen, F; Niederacher, D; Krawczyk, N; Ruckhaeberle, E; Fehm, T; Neubauer, H

Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center

在综合癌症中心,补充和替代医学与妇科癌症门诊患者的癌症治疗之间可能存在的相互作用

Zeller, T; Muenstedt, K; Stoll, C; Schweder, J; Senf, B; Ruckhaeberle, E; Becker, S; Serve, H; Huebner, J

Clinical relevance of the putative stem cell marker p63 in breast cancer

乳腺癌中推定的干细胞标志物 p63 的临床意义

L Hanker, T Karn, E Ruckhaeberle, R Gaetje, C Solbach, M Schmidt, K Engels, U Holtrich, M Kaufmann, A Rody